JP2009521214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009521214A5 JP2009521214A5 JP2008547136A JP2008547136A JP2009521214A5 JP 2009521214 A5 JP2009521214 A5 JP 2009521214A5 JP 2008547136 A JP2008547136 A JP 2008547136A JP 2008547136 A JP2008547136 A JP 2008547136A JP 2009521214 A5 JP2009521214 A5 JP 2009521214A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- composition
- composition according
- oligosaccharide
- nutritional composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 34
- 235000016709 nutrition Nutrition 0.000 claims 18
- 229920001542 oligosaccharide Polymers 0.000 claims 9
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 claims 6
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims 4
- 208000008589 Obesity Diseases 0.000 claims 4
- 235000014113 dietary fatty acids Nutrition 0.000 claims 4
- 229930195729 fatty acid Natural products 0.000 claims 4
- 239000000194 fatty acid Substances 0.000 claims 4
- 150000004665 fatty acids Chemical class 0.000 claims 4
- 235000020778 linoleic acid Nutrition 0.000 claims 4
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims 4
- 235000020824 obesity Nutrition 0.000 claims 4
- 150000002482 oligosaccharides Chemical class 0.000 claims 4
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 claims 3
- 235000019197 fats Nutrition 0.000 claims 3
- 150000002632 lipids Chemical class 0.000 claims 3
- 230000035764 nutrition Effects 0.000 claims 3
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 claims 3
- 229940045145 uridine Drugs 0.000 claims 3
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims 2
- 229960001231 choline Drugs 0.000 claims 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims 2
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 claims 2
- 150000004667 medium chain fatty acids Chemical class 0.000 claims 2
- -1 phosphorus lipid Chemical class 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 1
- 229920001202 Inulin Polymers 0.000 claims 1
- DJJCXFVJDGTHFX-UHFFFAOYSA-N Uridinemonophosphate Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000011575 calcium Substances 0.000 claims 1
- 229910052791 calcium Inorganic materials 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims 1
- 229940107187 fructooligosaccharide Drugs 0.000 claims 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims 1
- 229940029339 inulin Drugs 0.000 claims 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 125000003835 nucleoside group Chemical group 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 235000004252 protein component Nutrition 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 claims 1
- 150000003408 sphingolipids Chemical class 0.000 claims 1
- DJJCXFVJDGTHFX-XVFCMESISA-N uridine 5'-monophosphate Chemical group O[C@@H]1[C@H](O)[C@@H](COP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 DJJCXFVJDGTHFX-XVFCMESISA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20050077972 EP1800675B1 (en) | 2005-12-23 | 2005-12-23 | Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia |
| PCT/NL2006/050274 WO2008054192A1 (en) | 2006-11-02 | 2006-11-02 | Use of nutritional compositions for preventing disorders |
| PCT/NL2006/050329 WO2007073193A2 (en) | 2005-12-23 | 2006-12-22 | Infant nutritional compositions for preventing obesity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009521214A JP2009521214A (ja) | 2009-06-04 |
| JP2009521214A5 true JP2009521214A5 (enExample) | 2010-02-18 |
Family
ID=37964343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008547136A Pending JP2009521214A (ja) | 2005-12-23 | 2006-12-22 | 肥満防止のための乳幼児用栄養組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (4) | US20090186803A1 (enExample) |
| EP (4) | EP1973424B1 (enExample) |
| JP (1) | JP2009521214A (enExample) |
| CN (1) | CN103054048B (enExample) |
| AU (3) | AU2006327996B2 (enExample) |
| BR (3) | BRPI0620466A2 (enExample) |
| CA (3) | CA2634117A1 (enExample) |
| ES (1) | ES2537080T3 (enExample) |
| HU (1) | HUE026440T2 (enExample) |
| MY (2) | MY149164A (enExample) |
| PL (1) | PL1962823T3 (enExample) |
| PT (1) | PT1962823E (enExample) |
| RU (3) | RU2414905C2 (enExample) |
| WO (3) | WO2007073193A2 (enExample) |
Families Citing this family (74)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008054192A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
| TW200917972A (en) * | 2007-09-07 | 2009-05-01 | Nestec Sa | Range of shelf stable infant foods which include only naturally contained sugars and methods for making the same |
| US20100261642A1 (en) * | 2007-09-17 | 2010-10-14 | N.V. Nutricia | Nutritional formulation with high energy content |
| CN103202353A (zh) | 2007-11-01 | 2013-07-17 | 恩兹默泰克有限公司 | 用于婴儿营养的脂质混合物 |
| CN101945589A (zh) * | 2007-12-21 | 2011-01-12 | 荷兰纽迪希亚公司 | 用于改善肠道微生物群的非消化性碳水化合物的用途 |
| WO2009085265A1 (en) * | 2007-12-31 | 2009-07-09 | Nestec S.A. | Nutritionally appropriate menu of food products for toddlers |
| EP2143341A1 (en) | 2008-07-08 | 2010-01-13 | Nestec S.A. | Nutritional Composition Containing Oligosaccharide Mixture |
| CN104605359A (zh) * | 2008-06-16 | 2015-05-13 | N·V·努特里奇亚 | 具有脂肪梯度的组合物 |
| US9491955B2 (en) | 2008-08-25 | 2016-11-15 | Brandeis University | Balanced myristate- and laurate-containing edible oil |
| DK2341784T3 (da) | 2008-09-02 | 2013-02-04 | Nutricia Nv | Næringspræparater med coatede lipidkugler |
| NZ571856A (en) * | 2008-10-09 | 2011-02-25 | Fonterra Corporate Res And Dev Ltd | Use of a phospholipid and ganglioside composition for the treatment or prevention of gout |
| EP2452574A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for young infants |
| MX2011004921A (es) | 2008-12-08 | 2011-05-30 | Nestec Sa | Modulacion de la grasa corporal infantil. |
| WO2010068086A1 (en) * | 2008-12-11 | 2010-06-17 | N.V. Nutricia | Nutritional compositions with large lipid globule size |
| CA2749254A1 (en) * | 2009-01-19 | 2010-07-22 | Catherine Mace | Nutritional composition for infants |
| WO2010106384A1 (fr) * | 2009-03-16 | 2010-09-23 | Societe La Biochimie Appliquee (Solabia) | Compositions nutraceutiques, pharmaceutiques ou alimentaires a base de gluco-oligosaccharides |
| MY161505A (en) * | 2009-04-01 | 2017-04-14 | Nestec Sa | Reduction of risk of obesity |
| WO2010119088A2 (en) * | 2009-04-15 | 2010-10-21 | Bodo Melnik | Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
| WO2011071367A1 (en) | 2009-12-11 | 2011-06-16 | N.V. Nutricia | Metabolic imprinting effects of structured lipids |
| PL2353595T3 (pl) | 2010-01-19 | 2016-03-31 | Mjn Us Holdings Llc | Kompensacja żywieniowa w diecie typu zachodniego |
| JP5581071B2 (ja) | 2010-02-03 | 2014-08-27 | 花王株式会社 | ミトコンドリア機能向上剤 |
| WO2011115476A1 (en) | 2010-03-17 | 2011-09-22 | N.V. Nutricia | Infant nutrition for improving fatty acid composition of brain membranes later in life |
| EP2452573A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional composition with animal fats and vegetable fats |
| EP2452572A1 (en) * | 2010-11-15 | 2012-05-16 | Nestec S.A. | Age-tailored nutritional formula with particularly adapted caloric density for infants and children |
| CA2827579A1 (en) * | 2011-02-16 | 2012-08-23 | Pivotal Therapeutics, Inc. | Omega 3 formulations comprising epa, dha and dpa for treatment of risk factors for cardiovascular disease |
| WO2012112520A1 (en) * | 2011-02-16 | 2012-08-23 | Pivotal Therapeutics, Inc. | A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| CA2827561A1 (en) * | 2011-02-16 | 2012-08-23 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid diagniostic assay for the dietary management of patients with cardiovascular disease (cvd) |
| EP2675442A1 (en) * | 2011-02-16 | 2013-12-25 | Pivotal Therapeutics, Inc. | Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| EP2514435A1 (en) * | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
| WO2012173467A1 (en) | 2011-06-16 | 2012-12-20 | N.V. Nutricia | Metabolic imprinting effects of specifically designed lipid component |
| WO2013036103A1 (en) * | 2011-09-08 | 2013-03-14 | N.V. Nutricia | Use of infant formula with large lipid globules |
| WO2013036102A1 (en) * | 2011-09-08 | 2013-03-14 | N.V. Nutricia | Use of infant formula with cholesterol |
| MX350436B (es) * | 2011-10-18 | 2017-09-06 | Nestec Sa | Composicion para uso en el aumento de sensibilidad a la insulina y/o la reduccion de resistencia a la insulina. |
| EP2583562A1 (en) | 2011-10-21 | 2013-04-24 | Nestec S.A. | Use of whey protein micelles for infants at risk of obesity or diabetes |
| AU2013221572B2 (en) * | 2012-02-17 | 2017-12-21 | Alcresta Therapeutics, Inc. | Methods, compositions, and devices for supplying dietary fatty acid needs |
| SE536599C3 (sv) * | 2012-04-10 | 2017-01-10 | Hero Ag | Näringssammansättning med lågt kalori- och lågt proteininnehåll |
| WO2013191533A1 (en) | 2012-06-18 | 2013-12-27 | N.V. Nutricia | Metabolic imprinting effects of nutrition with large lipid globules comprising milk fat and vegetable fat |
| WO2014058301A1 (en) * | 2012-10-12 | 2014-04-17 | N.V. Nutricia | Infant nutrition with lipid globules to increase energy expenditure and metabolic flexibility later in life |
| US10251928B2 (en) | 2014-11-06 | 2019-04-09 | Mead Johnson Nutrition Company | Nutritional supplements containing a peptide component and uses thereof |
| EP2986155A1 (en) * | 2013-04-10 | 2016-02-24 | Nestec S.A. | Infant formula with a low content of medium-chain fatty acids in specific proportions, and its use in promoting and/or ensuring a balanced growth in infants |
| RU2654739C2 (ru) * | 2013-04-10 | 2018-05-22 | Нестек С.А. | Детская смесь с низким содержанием mcfa в определенных пропорциях и относительно высоким содержанием жирных кислот и ее применение в стимуляции здорового становления когнитивной функции у грудных детей |
| SE537951C2 (sv) * | 2013-07-01 | 2015-12-01 | Hero Ag | Profylaktisk användning av modersmjölksersättning mot otit |
| WO2015065193A1 (en) | 2013-11-01 | 2015-05-07 | N.V. Nutricia | Lipid composition for improving body composition during catch-up growth |
| WO2015078938A1 (en) * | 2013-11-29 | 2015-06-04 | Nestec S.A. | Age-tailored nutritional compositions with a varying protein content |
| MX2016006576A (es) * | 2013-11-29 | 2016-08-03 | Nestec Sa | Composiciones nutritivas con fosfolipidos. |
| EP3074899A1 (en) * | 2013-11-29 | 2016-10-05 | Nestec S.A. | Devices, systems and methods of assessing the risk of obesity later in life of an infant or a young child |
| WO2015086176A1 (en) | 2013-12-12 | 2015-06-18 | Nestec S.A. | Synthetic milk compositions for infants less than three months old and for infants and children more than three months for ensuring optimal growth and preventing obesity |
| ES2725610T3 (es) * | 2013-12-12 | 2019-09-25 | Nestle Sa | Composiciones lácteas sintéticas que comprenden ácidos grasos poliinsaturados (PUFAS) para fomentar el establecimiento saludable de la función cognitiva en lactantes y niños varones y hembras |
| EP3079500B1 (en) | 2013-12-12 | 2019-06-19 | Nestec S.A. | Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children |
| EP3079497B1 (en) | 2013-12-12 | 2019-10-23 | Société des Produits Nestlé S.A. | Synthetic milk compositions comprising n-6 eicosatrienoic acid and polar lipids for infants younger and older than three months for healthy establishment of cognitive function |
| JP6336750B2 (ja) * | 2013-12-19 | 2018-06-06 | 雪印メグミルク株式会社 | 脂肪蓄積抑制剤 |
| AU2015327029B2 (en) * | 2014-09-30 | 2019-10-03 | Société des Produits Nestlé S.A. | Nutritional composition with low content of medium-chain fatty acids in specific proportions, and its uses. |
| US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
| US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
| US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
| EP3285602A1 (en) * | 2015-04-21 | 2018-02-28 | Enzymotec Ltd. | Compositions comprising choline and derivatives thereof, uses thereof and processes for their preparation |
| JP6613661B2 (ja) * | 2015-07-08 | 2019-12-04 | 花王株式会社 | 食品に対する内臓脂肪のつきにくさの評価方法 |
| PL3361885T3 (pl) | 2015-10-15 | 2019-11-29 | Nutricia Nv | Preparat do początkowego żywienia niemowląt mający specjalną architekturę lipidów do pobudzania zdrowego wzrostu |
| RU2735250C2 (ru) * | 2016-01-26 | 2020-10-29 | Сосьете Де Продюи Нестле С.А. | КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ 2FL И LNnT, ДЛЯ КОНТРОЛЯ ПОТРЕБЛЕНИЯ ПИЩИ И РОСТА У МЛАДЕНЦЕВ ИЛИ ДЕТЕЙ МЛАДШЕГО ВОЗРАСТА |
| AU2017251143B2 (en) * | 2016-04-11 | 2021-05-20 | Société des Produits Nestlé S.A. | Infant nutrition delivering metabolic benefits |
| WO2017183956A1 (en) * | 2016-04-18 | 2017-10-26 | N.V. Nutricia | Linoleic acid and alpha-linolenic acid for use for reducing early-life stress induced cognitive decline |
| WO2017183970A1 (en) * | 2016-04-18 | 2017-10-26 | N.V. Nutricia | Linoleic acid and alpha-li nolenic acid for use for reducing early-life stress induced cognitive decline/reduction in neurogenesis |
| EP3471562A4 (en) * | 2016-06-15 | 2020-07-29 | Glycom A/S | Synthetic compositions comprising human milk oligosaccharides for use the prevention and treatment of disorders |
| MY196605A (en) | 2016-12-09 | 2023-04-20 | Nutricia Nv | Nutritional Composition for Improving Cell Membranes |
| BR112019028039A2 (pt) | 2017-06-30 | 2020-07-07 | N.V. Nutricia | composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia |
| EP3645024B1 (en) | 2017-06-30 | 2022-09-14 | N.V. Nutricia | Synbiotic composition for preventing fatty liver disease |
| WO2019162475A1 (en) * | 2018-02-23 | 2019-08-29 | Firmenich Sa | Shelf stable powdered composition |
| US12005083B1 (en) | 2019-06-24 | 2024-06-11 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
| US11849747B1 (en) | 2019-06-24 | 2023-12-26 | PBM Nutritionals, LLC | Nutritional compositions with MFGM and certain human milk oligosaccharides and uses thereof |
| WO2021086255A1 (en) * | 2019-10-29 | 2021-05-06 | Aak Ab (Publ) | Nutritional composition comprising milk and egg phospholipids |
| CN114052243A (zh) * | 2020-07-29 | 2022-02-18 | 江苏伯克投资管理有限公司 | 山羊乳提取物的制备及其在全营养特殊医学用途配方食品中的应用 |
| CN112972488B (zh) * | 2021-03-02 | 2022-12-23 | 青岛农业大学 | 一种具有抗高尿酸血症活性的岩藻寡糖及其制备方法和应用 |
| CN118102890A (zh) * | 2021-10-13 | 2024-05-28 | 雀巢产品有限公司 | 用于改善睡眠的营养组合物 |
| WO2023208925A1 (en) | 2022-04-25 | 2023-11-02 | N.V. Nutricia | Nutritional composition for use in preventing programmed obesity in female infants |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59187787A (ja) * | 1983-04-11 | 1984-10-24 | Meito Sangyo Kk | 酵素法スフインゴリン脂質誘導体の製法 |
| ES2033193B1 (es) * | 1990-10-30 | 1994-01-16 | Ganadera Union Ind Agro | Mezcla grasa para nutricion infantil y de adultos. |
| JPH05304297A (ja) * | 1992-01-29 | 1993-11-16 | Nec Corp | 電力用半導体装置およびその製造方法 |
| US5602109A (en) * | 1994-01-10 | 1997-02-11 | Abbott Laboratories | Method to enhance the immune system of a human |
| US6194009B1 (en) * | 1996-11-22 | 2001-02-27 | Princeton Nutrition, Llc | Refrigeration-shelf-stable ultra-pasteurized or pasteurized infant formula |
| NZ337039A (en) * | 1997-02-21 | 2001-06-29 | Univ Tennessee Res Corp | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing entercolitis |
| JPH10262607A (ja) * | 1997-03-28 | 1998-10-06 | Snow Brand Milk Prod Co Ltd | 乳幼児用栄養組成物 |
| US6413557B1 (en) * | 1997-07-02 | 2002-07-02 | Kyung Ja Lee | Soy-containing nutrition supplement and process |
| DE69718455T2 (de) * | 1997-07-22 | 2003-04-30 | Societe Des Produits Nestle S.A., Vevey | Lipidzusammensetzung für Säuglingsnährpräparat und Herstellungsverfahren |
| US6579551B1 (en) * | 1998-05-21 | 2003-06-17 | Beech-Nut Nutrition Corporation | Baby-food compositions containing egg yolk and methods therefor |
| US6149964A (en) * | 1998-05-21 | 2000-11-21 | Beech-Nut Nutrition Corporation | Egg yolk-containing baby food compositions and methods therefor |
| ES2187115T3 (es) * | 1999-01-20 | 2003-05-16 | Nutricia Nv | Preparado para lactantes. |
| PL199861B1 (pl) * | 1999-04-29 | 2008-11-28 | Nestle Sa | Preparat dla niemowląt i sposób wytwarzania preparatu |
| JP3544493B2 (ja) * | 1999-06-10 | 2004-07-21 | 雪印乳業株式会社 | 乳幼児用栄養組成物 |
| US6465714B2 (en) * | 1999-11-05 | 2002-10-15 | Arexis Ab | Congenic animal models of non-insulin dependent diabetes mellitus |
| CA2432884C (en) * | 2000-12-27 | 2008-01-22 | N.V. Nutricia | Nutritional composition with health promoting action containing oligosaccharides |
| US7090862B2 (en) * | 2001-03-30 | 2006-08-15 | Abbott Laboratories | Method of improving the antioxidant status of an infant |
| AU2002320407A1 (en) | 2001-07-10 | 2003-01-29 | Trustees Of Boston University | Modified-fat nutritional products useful for preventing or treating obesity |
| IL150240A (en) * | 2002-06-16 | 2005-07-25 | Lipogen Ltd | Infant formula supplemented with phospholipids |
| US20040013787A1 (en) * | 2002-06-28 | 2004-01-22 | Theuer Richard C. | Fat compositions for infant formula and methods therefor |
| SE526943C2 (sv) * | 2002-08-26 | 2005-11-22 | Indevex Ab | Födoämneskompositionsprodukt |
| US20050175759A1 (en) * | 2004-02-09 | 2005-08-11 | Atul Singhal | Newborn infant formulas and feeding methods |
| US6753350B1 (en) * | 2003-03-24 | 2004-06-22 | Bristol-Myers Squibb Company | Method to reduce the incidence of intraventricular hemorrhage in preterm infants |
| US6998392B2 (en) * | 2003-04-02 | 2006-02-14 | Mti Meta Tech Inc. | Formulation to treat or prevent parasitic infection |
| ES2326481T3 (es) * | 2003-06-23 | 2009-10-13 | Nestec S.A. | Formula para recien nacidos o formula de continuacion. |
| CA2530170A1 (en) * | 2003-06-24 | 2005-01-06 | University Of Kansas Medical Center | Infant formula |
| IL158554A0 (en) * | 2003-10-22 | 2004-05-12 | Enzymotec Ltd | Mimetic lipids as dietary supplements |
| WO2005063050A1 (en) | 2003-12-19 | 2005-07-14 | Abbott Laboratories | Method of increasing lean body mass and reducing body fat mass in infants |
| EP1566439A1 (en) * | 2004-02-20 | 2005-08-24 | Nestec S.A. | Preventing or treating obesity |
| ES2467093T3 (es) * | 2004-07-19 | 2014-06-11 | N.V. Nutricia | Preparación para usar de aspartato y vitamina B12 o biotina para regular los cuerpos cetónicos |
| EP1634599A1 (en) * | 2004-08-20 | 2006-03-15 | N.V. Nutricia | Iimmune stimulatory infant nutrition |
| EP1656839A1 (en) * | 2004-11-11 | 2006-05-17 | N.V. Nutricia | Nutrition containing lipid blend |
| DE602004015169D1 (de) | 2004-11-26 | 2008-08-28 | Nutricia Nv | Kleinkindernahrung mit proteasehemmer |
| BRPI0519507A2 (pt) * | 2004-12-27 | 2009-03-10 | Nestec Sa | uso de fàrmula lactente com teor de proteÍna reduzido |
| WO2006091103A2 (en) * | 2005-02-28 | 2006-08-31 | N.V. Nutricia | Nutritional composition with probiotics |
| AU2006221947B2 (en) * | 2005-03-08 | 2011-05-12 | Nestec S.A. | Extruded solid product for use in foodstuffs |
| US20070191264A1 (en) * | 2005-05-05 | 2007-08-16 | Bristol-Myers Squibb Company, A Delaware Corporation | Methods for inhibiting the growth of bacteria |
-
2006
- 2006-12-22 EP EP06824324.5A patent/EP1973424B1/en active Active
- 2006-12-22 RU RU2008130367/15A patent/RU2414905C2/ru not_active IP Right Cessation
- 2006-12-22 AU AU2006327996A patent/AU2006327996B2/en active Active
- 2006-12-22 BR BRPI0620466-0A patent/BRPI0620466A2/pt not_active Application Discontinuation
- 2006-12-22 AU AU2006327995A patent/AU2006327995B2/en not_active Ceased
- 2006-12-22 CA CA002634117A patent/CA2634117A1/en not_active Abandoned
- 2006-12-22 RU RU2008130365/13A patent/RU2444210C2/ru not_active IP Right Cessation
- 2006-12-22 RU RU2008130370/13A patent/RU2417712C2/ru active
- 2006-12-22 BR BRPI0620465-1A patent/BRPI0620465A2/pt not_active Application Discontinuation
- 2006-12-22 AU AU2006327997A patent/AU2006327997B2/en active Active
- 2006-12-22 BR BRPI0620451-1A patent/BRPI0620451A2/pt not_active IP Right Cessation
- 2006-12-22 EP EP11150747A patent/EP2305049A1/en not_active Withdrawn
- 2006-12-22 US US12/158,931 patent/US20090186803A1/en not_active Abandoned
- 2006-12-22 WO PCT/NL2006/050329 patent/WO2007073193A2/en not_active Ceased
- 2006-12-22 CA CA002634895A patent/CA2634895A1/en not_active Abandoned
- 2006-12-22 EP EP06824326.0A patent/EP1962823B1/en not_active Revoked
- 2006-12-22 CA CA002634693A patent/CA2634693A1/en not_active Abandoned
- 2006-12-22 PT PT68243260T patent/PT1962823E/pt unknown
- 2006-12-22 WO PCT/NL2006/050328 patent/WO2007073192A2/en not_active Ceased
- 2006-12-22 MY MYPI20082246A patent/MY149164A/en unknown
- 2006-12-22 PL PL06824326T patent/PL1962823T3/pl unknown
- 2006-12-22 EP EP06824323A patent/EP1962617A2/en not_active Withdrawn
- 2006-12-22 WO PCT/NL2006/050331 patent/WO2007073194A2/en not_active Ceased
- 2006-12-22 CN CN201310014398.XA patent/CN103054048B/zh active Active
- 2006-12-22 JP JP2008547136A patent/JP2009521214A/ja active Pending
- 2006-12-22 US US12/158,857 patent/US20110136732A1/en not_active Abandoned
- 2006-12-22 ES ES06824326.0T patent/ES2537080T3/es active Active
- 2006-12-22 HU HUE06824326A patent/HUE026440T2/en unknown
- 2006-12-23 MY MYPI20082287A patent/MY162091A/en unknown
-
2012
- 2012-01-24 US US13/357,109 patent/US8871218B2/en active Active
-
2016
- 2016-03-01 US US15/057,324 patent/US20160175393A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009521214A5 (enExample) | ||
| RU2008130370A (ru) | Питательные композиции для младенцев для предупреждения ожирения | |
| AU2005274266B2 (en) | Immune stimulatory infant nutrition | |
| CN102497869B (zh) | 作为具有新功能益处的母乳等同性不可消化低聚糖的岩藻糖基乳糖 | |
| AU2005303903B2 (en) | Nutrition containing fat blend | |
| RU2011104077A (ru) | Питательная композиция со свободными аминокислотами и структурированными липидами | |
| PT1613169E (pt) | Composições e métodos de formulação de fórmulas entéricas contendo ácido siálico | |
| CN101360490A (zh) | 具有二十二碳五烯酸的组合物 | |
| WO2011008086A1 (en) | Mixture of non-digestible oligosaccharides for stimulating the immune system | |
| US20160331772A1 (en) | Composition Comprising a Uridine Source, an Omega-3 PUFA for Improving Coordination, Balance, Grip Strength or Fine Motor Skills | |
| BRPI0611245A2 (pt) | fàrmula infantil e seus usos | |
| BRPI0619464A2 (pt) | uso de sacarìdeos de ácido urÈnico, preferivelmente combinados com oligossacarìdeos neutros | |
| RU2007110843A (ru) | Композиция, содержащая ферментируемые полисахариды | |
| WO2012009426A1 (en) | High tolerance infant formula including hydrolyzed protein | |
| JP2025514761A (ja) | 糖尿病の発症を遅らせる又は糖尿病のリスクを軽減するための方法及び組成物 | |
| RU2605198C2 (ru) | Способ для снижения распространения инфекции у детей младшего возраста | |
| Jiménez et al. | Uses and Applications of Docosahexaenoic Acid (DHA) in Pediatric Gastroenterology: Current Evidence and New Perspective | |
| Robson | Preventing the epidemic of non-communicable diseases: an overview | |
| ES2971322T3 (es) | Fibra dietética para el tratamiento de pacientes que padecen acidemia metilmalónica y acidemia propiónica | |
| PT2461701E (pt) | Formulação alimentar compreendendo glicogénio | |
| Savino et al. | Hypoantigenic (HA) milk formula and blood cholesterol level in infants at 3 months of age |